Legend Biotech LEGN
$15.25 −$0.85 (-5.28%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $15.44 +1.25%
Open$15.95
Prev close$16.10
Day range$15.15 – $16.13
Volume3.42M
Market cap$2.96B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$359.50M+32.0% YoY
Operating profit$46.80M+208.1% YoY
Net profit$51.70M+230.6% YoY
Diluted EPS$0.26+218.2% YoY
Free cash flow-$41.50M-274.4% YoY
Operating cash flow-$35.90M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin57.0%
Operating margin2.6%
Net margin0.0%
Return on equity0.0%
Return on assets0.0%
Return on invested capital-0.4%
Current ratio3.95
Liabilities / assets24.3%
Cash & investments$852.50M
Total debt$155.60M
Net cash (debt)$696.90M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $359.50M | $387.50M | $305.10M | $1.03B | $306.40M |
| Total Operating Revenue | $359.50M | $387.50M | $305.10M | $1.03B | $306.40M |
| Cost of Revenue | $147.60M | $137.40M | $175.90M | $408.10M | $123.50M |
| Gross Profit | $211.90M | $250.10M | $129.20M | $620.80M | $182.90M |
| Operating Expense | $165.10M | $192.40M | $179.00M | $757.30M | $202.50M |
| Selling and Admin Expenses | $69.80M | $96.40M | $90.10M | $341.60M | $101.20M |
| -Selling & Marketing Expense | $55.00M | $63.40M | $50.10M | $205.80M | $64.20M |
| -General & Admin Expense | $14.80M | $33.00M | $40.00M | $135.80M | $37.00M |
| Research & Development | $95.30M | $96.00M | $85.70M | $414.70M | $101.30M |
| Operating Profit | $46.80M | $57.70M | -$49.80M | -$136.50M | -$19.60M |
| Net Non-Operating Interest Income (Expense) | $4.40M | -$200,000.00 | $1.80M | $18.70M | $2.50M |
| Non-Operating Interest Income | $8.30M | $5.60M | $7.30M | $40.10M | $8.00M |
| Non-Operating Interest Expense | $3.90M | $5.80M | $5.50M | $21.40M | $5.50M |
| Other Income (Expense) | -$1.80M | -$2.00M | -$5.10M | -$164.80M | -$2.50M |
| Gain on Sale of Security | -$2.00M | -$2.50M | -$5.90M | -$168.80M | -$3.50M |
| Other Non-Operating Income (Expenses) | $200,000.00 | $500,000.00 | $800,000.00 | $4.00M | $1.00M |
| Pretax Profit | $49.40M | $55.50M | -$53.10M | -$282.60M | -$19.60M |
| Tax | -$2.30M | $22.30M | $1.20M | $14.20M | $11.20M |
| Net Profit | $51.70M | $33.20M | -$54.30M | -$296.80M | -$30.80M |
| Profit from Continuing Operations | $51.70M | $33.20M | -$54.30M | -$296.80M | -$30.80M |
| Net Income to Parent Company | $51.70M | $33.20M | -$54.30M | -$296.80M | -$30.80M |
| Net Income to Common Stockholders | $51.70M | $33.20M | -$54.30M | -$296.80M | -$30.80M |
| Basic EPS | $0.26 | $0.18 | -$0.30 | -$1.62 | -$0.16 |
| Diluted EPS | $0.26 | $0.18 | -$0.30 | -$1.62 | -$0.16 |
| Other Operating Expenses | – | – | $3.20M | $1.00M | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.68B | $1.75B | $1.60B | $1.73B | $1.73B |
| Total Current Assets | $1.14B | $1.23B | $1.08B | $1.25B | $1.25B |
| Cash and Cash Equivalents & Short-Term Investments | $852.50M | $964.60M | $834.60M | $948.60M | $948.60M |
| -Cash and Cash Equivalents | $460.70M | $672.90M | $646.40M | $901.90M | $901.90M |
| -Short Term Investments | $391.80M | $291.70M | $188.20M | $46.70M | $46.70M |
| Receivables | $218.90M | $198.00M | $186.60M | $250.30M | $250.30M |
| -Accounts Receivable | $0.00 | $0.00 | $1.70M | $13.10M | $13.10M |
| -Taxes Receivable | $13.10M | $11.90M | $10.90M | $8.10M | $8.10M |
| -Other Receivables | $205.80M | $186.10M | $174.00M | $229.10M | $229.10M |
| Prepaid Assets | $23.50M | $18.50M | $19.40M | $14.60M | $14.60M |
| Inventory | $39.80M | $41.50M | $37.10M | $32.00M | $32.00M |
| Other Current Assets | $10.10M | $4.80M | $5.00M | $1.60M | $1.60M |
| Total Non-Current Assets | $536.60M | $523.50M | $514.00M | $486.60M | $486.60M |
| Net PPE | $439.50M | $448.20M | $452.50M | $402.00M | $402.00M |
| -Gross PPE | $439.50M | $448.20M | $452.50M | $455.50M | $455.50M |
| Goodwill and Other Intangible Assets | $71.30M | $49.80M | $35.00M | $74.60M | $74.60M |
| -Other Intangible Assets | $71.30M | $49.80M | $35.00M | $74.60M | $74.60M |
| Other Non-Current Assets | $25.80M | $25.50M | $26.50M | – | – |
| Total Liabilities | $408.70M | $521.30M | $629.00M | $731.60M | $731.60M |
| Total Current Liabilities | $289.60M | $403.60M | $509.10M | $636.40M | $636.40M |
| Payables | $117.10M | $130.50M | $224.80M | $184.30M | $184.30M |
| -Accounts Payable | $72.00M | $77.30M | $74.30M | $81.20M | $81.20M |
| -Total Tax Payable | $30.00M | $33.70M | $20.30M | $27.10M | $27.10M |
| -Other Payable | $15.10M | $19.50M | $130.20M | $74.20M | $74.20M |
| Current Accrued Expenses | $115.50M | $103.10M | – | $113.30M | $113.30M |
| Short-Term Debt and Capital Lease Obligation | $55.90M | $168.20M | $277.20M | $326.50M | $326.50M |
| -Current Debt | $44.10M | $156.40M | $266.00M | $319.10M | $319.10M |
| -Current Capital Lease Obligation | $11.80M | $11.80M | $11.20M | $7.40M | $7.40M |
| Current Deferred Liabilities | $0.00 | $700,000.00 | $6.00M | $11.30M | $11.30M |
| Other Current Liabilities | $1.10M | $1.10M | $1.10M | $1.00M | $1.00M |
| Total Non-Current Liabilities | $119.10M | $117.70M | $119.90M | $95.20M | $95.20M |
| Long Term Debt and Capital Lease Obligation | $111.50M | $110.00M | $112.10M | $87.20M | $87.20M |
| -Long Term Capital Lease Obligation | $111.50M | $110.00M | $112.10M | $87.20M | $87.20M |
| Other Non-Current Liabilities | $7.60M | $7.70M | $7.80M | $8.00M | $8.00M |
| Total Equity | $1.27B | $1.23B | $967.70M | $1.00B | $1.00B |
| Stockholders' Equity | $1.27B | $1.23B | $967.70M | $1.00B | $1.00B |
| Capital Stock | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 |
| -Common Stock | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 |
| Additional Paid-In Capital | $3.02B | $3.01B | $2.78B | $2.75B | $2.75B |
| Retained Earnings | -$1.93B | -$1.98B | -$2.01B | -$1.96B | -$1.96B |
| Gains/Losses Not Affecting Retained Earnings | $122.60M | $121.40M | $122.70M | $122.20M | $122.20M |
| Other Equity Interests | $56.30M | $72.80M | $76.80M | $88.00M | $88.00M |
| -Accumulated Depreciation | – | – | – | -$53.50M | -$53.50M |
| Investments and Advances | – | – | – | $5.00M | $5.00M |
| -Available for Sale Securities | – | – | – | $5.00M | $5.00M |
| Non-Current Prepaid Assets | – | – | – | $5.00M | $5.00M |
| -Due to Related Parties Current | – | – | – | $1.80M | $1.80M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$35.90M | -$20.90M | -$85.10M | -$100.20M | -$12.20M |
| Net cash flow from continuing operations | -$35.90M | -$20.90M | -$85.10M | -$100.20M | -$12.20M |
| Net Income from Continuing Operations | $49.40M | $55.50M | -$53.10M | -$282.60M | -$19.60M |
| Gain/Loss from Continuing Operations | $2.50M | $700,000.00 | $5.90M | $168.80M | $3.40M |
| Depreciation & Depletion & Amortization | $11.00M | $11.70M | $15.60M | $28.90M | $12.00M |
| Other Non-Cash Items | -$3.80M | -$200,000.00 | $1.00M | -$17.40M | -$2.50M |
| Change in Working Capital | -$94.20M | -$100.40M | -$75.30M | -$93.10M | -$31.10M |
| -Change in Receivables | -$100,000.00 | $1.60M | $11.40M | -$5.70M | -$11.20M |
| -Change in Inventory | $1.20M | -$6.00M | $700,000.00 | -$4.50M | -$3.80M |
| -Change in Prepaid Assets | -$95.10M | -$88.30M | -$7.00M | -$126.80M | -$41.20M |
| -Change in Payables and Accrued Expense | $2.30M | -$6.70M | -$73.30M | $80.50M | $31.20M |
| -Change In Other Working Capital | -$2.50M | -$1.00M | -$7.10M | -$36.60M | -$6.10M |
| Net cash flow from investing | -$124.90M | -$120.00M | -$168.00M | $709.60M | $638.50M |
| Net Cash Flow from Continuing Investing Activities | -$124.90M | -$120.00M | -$168.00M | $709.60M | $638.50M |
| Net PPE Purchase and Sale | -$5.60M | -$7.50M | -$7.50M | -$28.60M | -$12.40M |
| Net Investment Purchase and Sale | -$104.20M | -$99.40M | -$142.10M | $777.00M | $659.40M |
| Net Other Investing Changes | -$15.10M | -$13.10M | -$18.40M | -$38.80M | -$8.50M |
| Financing Cash Flow | -$50.70M | $167.70M | -$1.20M | -$300,000.00 | -$700,000.00 |
| Net Cash Flow from Continuing Financing Activities | -$50.70M | $167.70M | -$1.20M | -$300,000.00 | -$700,000.00 |
| Net Issuance Payments Of Debt | -$50.60M | -$44.90M | -$1.30M | -$3.60M | -$1.00M |
| Net Common Stock Issuance | -$800,000.00 | – | – | $0.00 | $0.00 |
| Proceeds from Stock Option Exercised | $700,000.00 | $200,000.00 | $100,000.00 | $3.30M | $300,000.00 |
| Ending Cash Balance | $460.70M | $672.90M | $646.40M | $901.90M | $901.90M |
| Net Change in Cash | -$211.50M | $26.80M | -$254.30M | $609.10M | $625.60M |
| Beginning Cash Balance | $672.90M | $646.40M | $901.90M | $286.70M | $278.90M |
| Effect of Exchange Rate Changes | -$700,000.00 | -$300,000.00 | -$1.20M | $6.10M | -$2.60M |
| Free Cash Flow | -$41.50M | -$28.40M | -$92.60M | -$128.80M | -$24.60M |
| Net Intangibles Purchase and Sale | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on LEGN.
Sign in to join the discussion.